Results 191 to 200 of about 55,450 (260)

The Expanding Role of Companion Diagnostics in Infectious Diseases: Lessons From Abacavir and Human Immunodeficiency Virus Care

iLABMED, Volume 4, Issue 2, Page 113-115, June 2026.
Yi‐Wei Tang, Eric von Hofe
wiley   +1 more source

Oral Microbiome Resilience During SARS‐CoV‐2 Infection and Diversity Shifts After COVID‐19 Vaccination in a Hispanic Population

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
The oral microbiome in Hispanics remains largely resilient during mild SARS‐CoV‐2 infection, showing minimal diversity changes, while COVID‐19 vaccination induces increased microbial evenness and compositional shifts. These findings highlight limited infection impact but suggest vaccination transiently reshapes oral microbial ecology.
Daniela Vargas‐Robles, Jean L. Santos Agrait, Jaleniz Suárez‐Pérez, Frances Vázquez, Anelisse Dominicci‐Maura, Carlos A. Sariol, Carmen Zorrilla, Josefina Romaguera, Filipa Godoy‐Vitorino   +8 more
wiley   +1 more source

Vaccination in Immune-Mediated Intestinal Diseases: Efficacy, Safety, and Future Directions. [PDF]

Vaccines (Basel)
Lahat A, Sharif K.
europepmc   +1 more source

Organoids: From Bench to Bedside Applications

MedComm, Volume 7, Issue 6, June 2026.
Organoids, as a groundbreaking biomedical research platform, utilize adult stem cells (ASCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs) as sources. By integrating specific growth and differentiation signals within an extracellular matrix (e.g., Matrigel), organoids guide cells to self‐assemble into three‐dimensional ...
Kelin Li, Rui Cao, Maochen Li, Zichao Tian, Huahao Fan, Bixia Hong, Xiaojuan Liu   +6 more
wiley   +1 more source

Acute hepatitis B infection escaping vaccination: A case report. [PDF]

Medicine (Baltimore)
Leonhard SE, Fioole DN, Benschop KSM, Willems RPJ, Petrignani M, Voordouw BCG, Smeets LC, Zaaijer HL.   +7 more
europepmc   +1 more source

Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies

MedComm, Volume 7, Issue 6, June 2026.
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by unleashing antitumor immunity. This review comprehensively examines the molecular mechanisms underlying key immune checkpoints—including PD‐1/PD‐L1, CTLA‐4, and TIM‐3—and their clinical applications.
Qintao Ge, Liu Yu, Jiahe Lu, Aihetaimujiang Anwaier, Xiyue Xiao, Yonghao Chen, Dingwei Ye, Hailiang Zhang, Wenhao Xu, Wenbin Dai   +9 more
wiley   +1 more source

Challenges and opportunities in combating viral hepatitis in India: insights from the Indian Hepatitis Summit 2025. [PDF]

BMC Proc
Shanmugam V, Ward J, Vijayakumar S, Khwairakpam G, James C, Shanmugam L, Girija V, Rewari BB.   +7 more
europepmc   +1 more source

Metabolic Regulation of Immune Responses: Molecular Mechanisms, Diseases, and Therapeutic Targets

MedComm, Volume 7, Issue 6, June 2026.
FBP1 loss drives immune evasion and therapy resistance by enhancing glycolysis, STAT3 activation, and PD‐L1 expression, leading to T cell exhaustion and NK cell inhibition. FBP1 restoration, via LNP‐mRNA or epigenetic modulation, reverses these immunosuppressive effects, reactivates cytotoxic T cells, promotes M1 macrophage polarization, and enhances ...
Chunwei Li, Ziqiang Liu, Dezheng Kong, Zhengze Li, Yiming Yan, Yanyu Dong, Lili Zhu, JiaNing Cao, Zhirui Fan, Gautam Sethi, Lifeng Li   +10 more
wiley   +1 more source

Vaccine cold chain and understanding what underpins vaccine security for vaccine preventable diseases. [PDF]

BMJ Med
Rukundo G, Moore M, Semukunzi H, Chatterjee S, Musabyimana JP, Mambo Muvunyi C, Green CA.   +6 more
europepmc   +1 more source

Single-Center Retrospective Study of Hospitalized Hepatitis A Cases in Southern Bulgaria, 2015-2023. [PDF]

Healthcare (Basel)
Hristamyan M, Zlatanova S, Rangelova V, Tsachev I.   +3 more
europepmc   +1 more source